Apricus Biosciences, Inc.

Apricus Biosciences, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. The stock will provide you with a reasonable dividend income. Apricus Biosciences, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Apricus Biosciences, Inc..
Log in to see more information.
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development a...

News